AnteoTech’s AnteoBind Technology Supports Covid-19 Home Test
The test uses AnteoTech’s AnteoBind technology to support significantly improved sensitivity, and is the first covid-19 rapid self-test authorized by the FDA.
Read MorePosted by Melanie Hamilton-Basich | Feb 22, 2021 | Covid 19 |
The test uses AnteoTech’s AnteoBind technology to support significantly improved sensitivity, and is the first covid-19 rapid self-test authorized by the FDA.
Read MorePosted by Laurie Bonner | Feb 22, 2021 | Compliance, Covid 19 |
The new guidances for medical product developers, specifically covering vaccines, diagnostics, and therapeutic products, address the emergence and potential future emergence of variants of SARS-CoV-2, the virus that causes covid-19.
Read MorePosted by Melanie Hamilton-Basich | Feb 19, 2021 | Colorectal, Research |
The study suggests that such liquid biopsies could help personalize treatment for oligometastatic colorectal cancer.
Read MorePosted by Melanie Hamilton-Basich | Feb 18, 2021 | Hematology & Serology, Research |
New research has shown that results of blood tests routinely performed by GPs everywhere contain a hidden fingerprint that can identify people silently developing potentially fatal liver cirrhosis.
Read MorePosted by Melanie Hamilton-Basich | Feb 18, 2021 | Sexually Transmitted Diseases |
The binx io provides results in about 30 minutes, which enables diagnosis and treatment of chlamydia and gonorrhea in a single visit.
Read More